Lung Diseases: all 3,319 studies

Page 6 of 34. Open to participants first (355), then studies with results posted, then the rest; newest registration first within each.

• Chronic Obstructive Pulmonary Disease Patient Preferences SurveyCompletedNCT02970422Results posted
• Bioavailability of Tiotropium + Olodaterol Fixed-dose Combination (5 μg/ 5 μg) in Chinese COPD PatientsCompletedNCT02969317Phase 1Results posted
• Pharmacokinetic Comparability of Benralizumab Using Accessorized Pre-Filled Syringe or Autoinjector in Healthy VolunteersCompletedNCT02968914Phase 1Results posted
• Study of Efficacy and Safety of Pirfenidone in Patients With Fibrotic Hypersensitivity PneumonitisTerminatedNCT02958917Phase 2Results posted
• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [ie, Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered With an Electronic eFlow Nebulizer System in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02951312Phase 2Results posted
• Assessment of the Safety and Ability of a Once-a-day Dose of an Orally Inhaled Medicine [i.e., Glycopyrrolate Inhalation Solution = GIS] to Improve Airflow in the Lungs When Delivered Using an eFlow Nebulizer in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02948582Phase 2Results posted
• OTIVACTO Spain Non Interventional StudyCompletedNCT02927795Results posted
• De-implementing Inhaled Steroids to Improve Care and Safety in COPDCompletedNCT02896257Not applicableResults posted
• Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO)TerminatedNCT02887820Not applicableResults posted
• RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials CooperativeCompletedNCT02867761Phase 3Results posted
• Vahelva Respimat Regulatory Post-marketing Surveillance in Korean Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02864407Results posted
• Adherence Study in COPD PatientsCompletedNCT02864342Phase 4Results posted
• Hepatitis C Virus(HCV) Heart and Lung StudyCompletedNCT02858180Phase 4Results posted
• Effect of Tiotropium + Olodaterol on Breathlessness in COPD PatientsCompletedNCT02853123Phase 4Results posted
• Long-term Use of Spiolto Respimat in Japanese Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT02850978Results posted
• The Effect of STIOLTO™ RESPIMAT® on Fatigue in Chronic Obstructive Pulmonary DiseaseCompletedNCT02845752Phase 4Results posted
• HFNC Effect on BCSS in Patients With COPDTerminatedNCT02825043Not applicableResults posted
• Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of AZD8871 in Healthy SubjectsCompletedNCT02814656Phase 1Results posted
• Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)CompletedNCT02808871Phase 2Results posted
• An Efficacy Study of Umeclidinium/Vilanterol With Tiotropium/Olodaterol in COPD PatientsCompletedNCT02799784Phase 4Results posted
• AMPLIFY - D6571C00001 Duaklir USA Phase III StudyCompletedNCT02796677Phase 3Results posted
• Preference Attributes of ELLIPTA Dry Powder Inhaler (DPI) and HANDIHALER DPI in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02786927Phase 4Results posted
• Antibiotic "Dysbiosis" in Preterm InfantsCompletedNCT02784821Phase 2Results posted
• Long Term Nitric Oxide Bioavailability on Vascular Health in Chronic Obstructive Pulmonary DiseaseCompletedNCT02774226Phase 2Results posted
• European Regulatory Science on Tobacco: Policy Implementation to Reduce Lung Diseases (EUREST-PLUS)CompletedNCT02773836Results posted
• Study to Assess Efficacy and Safety of PT009 Compared to PT005, PT008, and Symbicort® Turbuhaler® on Lung Function Over 24-Weeks in Subjects With Moderate to Very Severe COPDCompletedNCT02766608Phase 3Results posted
• Abituzumab in SSc-ILDTerminatedNCT02745145Phase 2Results posted
• Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02729051Phase 3Results posted
• A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos)CompletedNCT02727660Phase 3Results posted
• Stage 1 Study of ARALAST NP and GLASSIA in A1PI DeficiencyTerminatedNCT02722304Phase 3Results posted
• Assessment of Physical Functioning and Handling of Spiolto Respimat in Patients With COPD (OTIVACTO)TerminatedNCT02720757Results posted
• OTIVACTO Regional Center Vienna (RCV) Non-Interventional Study (NIS)CompletedNCT02719639Results posted
• Longitudinal Follow up to Assess Biomarkers Predictive of Emphysema Progression in Patients With COPD (Chronic Obstructive Pulmonary Disease)CompletedNCT02719184Results posted
• The Role of Ambulatory Oxygen in Improving the Effectiveness of Pulmonary Rehabilitation for COPD PatientsTerminatedNCT02707770Not applicableResults posted
• Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary DiseaseCompletedNCT02700919Phase 2Results posted
• Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPDCompletedNCT02683109Phase 4Results posted
• The Use of High Frequency Oscillations With NIV in Hypercapnic COPD ParticipantsTerminatedNCT02680639Not applicableResults posted
• Assessment of Physical Functioning and Handling of Spiolto® Respimat® in Patients With Chronic Obstructive Pulmonary Disease (COPD) Requiring Long-acting Dual Bronchodilation in Routine Clinical PracticeCompletedNCT02675517Results posted
• A Study to Assess the Effect of CK-2127107 on Physical Function in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT02662582Phase 2Results posted
• INtervention Study In overweiGHT Patients With COPDCompletedNCT02634268Not applicableResults posted
• An Open Label Extension Study to Evaluate Inhaled Treprostinil in Adult PH With ILD Including CPFETerminatedNCT02633293Phase 2/3Results posted
• Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFECompletedNCT02630316Phase 2/3Results posted
• Comparing the Efficacy of Tiotropium + Olodaterol Fixed Dose Combination (FDC) Over Tiotropium in Improvement of Lung Hyperinflation, Exercise Capacity and Physical Activity in Japanese COPD PatientsCompletedNCT02629965Phase 3Results posted
• A Study to Evaluate the Anti-inflammatory Effects of Solithromycin in Chronic Obstructive Pulmonary DiseaseTerminatedNCT02628769Phase 2Results posted
• Pragmatic Trial of Video Education in Nursing HomesCompletedNCT02612688Not applicableResults posted
• Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler DevicesCompletedNCT02596009Phase 4Results posted
• Beta-Blockers for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseTerminatedNCT02587351Phase 3Results posted
• Ease of Use and Correct Use Study of Placebo ELLIPTA® Inhaler in COPD SubjectsCompletedNCT02586493Phase 4Results posted
• Batefenterol/Fluticasone Furoate in Treatment of Chronic Obstructive Pulmonary DiseaseCompletedNCT02573870Phase 2Results posted
• Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02570165Phase 2Results posted
• Preference on the Feedback Mechanisms of Dose Delivery Confirmation With the Breezhaler® Device Compared to the Ellipta® Device in Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02551224Not applicableResults posted
• The Anti-inflammatory Effect of Prophylactic Macrolides on Children With Chronic Lung DiseaseCompletedNCT02544984Not applicableResults posted
• A Study to Evaluate the Safety, Efficacy and Changes in Induced Sputum and Blood Biomarkers Following Daily Repeat Doses of Inhaled GSK2269557 in Chronic Obstructive Pulmonary Disease (COPD) Subjects With Acute ExacerbationCompletedNCT02522299Phase 2Results posted
• A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02518139Phase 3Results posted
• Does Pulmonary Rehabilitation Improve Frailty?CompletedNCT02512874Not applicableResults posted
• Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02512510Phase 3Results posted
• Efficacy and Safety Study of Indacaterol Maleate/Glycopyrronium Bromide in Chronic Obstructive Pulmonary Disease (COPD) Patients.CompletedNCT02487498Phase 3Results posted
• Efficacy and Safety Study of QVA149 in COPD PatientsCompletedNCT02487446Phase 3Results posted
• Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02459080Phase 3Results posted
• Detecting Errors In Using Metered Dose Inhalers (MDI) Among Asthma And Chronic Obstructive Pulmonary Disease (COPD) PatientsCompletedNCT02447575Not applicableResults posted
• Effect of QVA149 (Indacaterol Maleate/Glycopyrronium Bromide) on Cardiac Function in COPD PatientsCompletedNCT02442206Phase 4Results posted
• Effect of Aclidinium/Formoterol on Lung Hyperinflation, Exercise Capacity and Physical Activity in Moderate to Severe COPD PatientsCompletedNCT02424344Phase 4Results posted
• Study to Evaluate Lumacaftor and Ivacaftor Combination Therapy in Subjects 12 Years and Older With Advanced Lung DiseaseCompletedNCT02390219Phase 3Results posted
• A Study of the Efficacy and Safety of NVA237 in Patients With Moderate to Severe COPDCompletedNCT02371629Phase 4Results posted
• Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary FibrosisCompletedNCT02370693Phase 2Results posted
• An Evaluation Of PF-03715455 In Moderate To Severe Chronic Obstructive Pulmonary DiseaseTerminatedNCT02366637Phase 2Results posted
• Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)CompletedNCT02347774Phase 3Results posted
• A Comparison Study Between the Fixed Dose Triple Combination of Fluticasone Furoate/ Umeclidinium/ Vilanterol Trifenatate (FF/UMEC/VI) With Budesonide/Formoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02345161Phase 3Results posted
• Tiotropium Respimat Versus HandiHaler on SaO2 and Sleep in COPD PatientsCompletedNCT02331940Not applicableResults posted
• Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary SyndromesCompletedNCT02324660Not applicableResults posted
• Targeted Retreatment of COPD ExacerbationsCompletedNCT02300220Phase 3Results posted
• Safety and Efficacy Study of Losmapimod (GW856553) in Frequently Exacerbating Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02299375Phase 2Results posted
• Comparing the Efficacy of Tiotropium + Olodaterol (5/5 µg) Fixed Dose Combination (FDC) Over Tiotropium 5µg in Reducing Moderate to Severe Exacerbations in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease.CompletedNCT02296138Phase 3Results posted
• An Efficacy Study of GSK2269557 Added to Standard Care in Subjects With an Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseCompletedNCT02294734Phase 2Results posted
• A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPDCompletedNCT02276222Phase 3Results posted
• A Study of Arformoterol Tartrate Inhalation Solution and Tiotropium Bromide on Re-hospitalization in Chronic Obstructive Pulmonary Disease (COPD) SubjectsTerminatedNCT02275481Phase 4Results posted
• A Study to Evaluate the Effect of the Combination of Umeclidinium (UMEC) and Vilanterol (VI) on Exercise Endurance Time (EET) in Participants With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02275052Phase 4Results posted
• Theophylline and Steroids in Chronic Obstructive Pulmonary Disease (COPD) StudyCompletedNCT02261727Phase 4Results posted
• A Study to Evaluate the Effect of Umeclidinium (UMEC) as Combination Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02257372Phase 4Results posted
• The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary DiseaseCompletedNCT02252588Phase 2Results posted
• Right Ventricular Hemodynamics Using Cardiac MRI in Patients COPD and OSACompletedNCT02244957Not applicableResults posted
• Pulmonary Embolism as a Cause of COPD ExacerbationsCompletedNCT02238639Not applicableResults posted
• A Phase IIa Study to Investigate the Efficacy and Safety of AZD7624 in Chronic Obstructive Pulmonary Disease (COPD) Patients While on Maintenance TherapyCompletedNCT02238483Phase 2Results posted
• A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02236611Phase 4Results posted
• Aides in Respiration Health Coaching for COPDCompletedNCT02234284Not applicableResults posted
• Extending Preservation and Assessment Time of Donor Lungs Using the Toronto EVLP System™ at a Dedicated EVLP FacilityCompletedNCT02234128Not applicableResults posted
• A Multicenter, 4-week Crossover (Total Duration 12 Weeks) to Determine the Impact of QVA149 on Nocturnal Oxygen Levels in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02233543Phase 4Results posted
• Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02231177Phase 1Results posted
• A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium Compared With Tiotropium in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT02207829Phase 3Results posted
• Efficacy and Safety Study of PT009, PT008, and PT005 in Subjects With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02196077Phase 2Results posted
• Study of Inhaler Device Attributes Investigating Critical and Overall Errors, Ease of Use, and Preference Between a Number of Inhaler DevicesCompletedNCT02184624Phase 4Results posted
• A 24 Week Efficacy Study of Inhaled Umeclidinium (UMEC) in Patients of Chronic Obstructive Pulmonary Disease (COPD) Using a Novel Dry Powder Inhaler (NDPI)CompletedNCT02184611Phase 3Results posted
• Pulmonary Rehab in Chronic Obstructive Pulmonary Disease (COPD): Response to TyvasoTerminatedNCT02178566Phase 2Results posted
• A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02164513Phase 3Results posted
• Asthma Data Innovation Demonstration ProjectCompletedNCT02162576Not applicableResults posted
• Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryCompletedNCT02155660Phase 3Results posted
• A Double-blind, Placebo-controlled, Crossover Study to Assess the Effect of Aclidinium Bromide 400 μg Bid on COPD Symptoms and Sleep Quality After 3 Weeks of Treatment in Patients With Stable Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02153489Phase 4Results posted
• A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT02152605Phase 3Results posted
• Benralizumab Efficacy in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation HistoryCompletedNCT02138916Phase 3Results posted
• TOPIC Trial for COPDCompletedNCT02135432Early Phase 1Results posted

← Lung Diseases overview